San Miguel, Peru Clinical Trials

A listing of San Miguel, Peru clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 99 clinical trials
Study of Durvalumab + Tremelimumab With Chemotherapy or Durvalumab With Chemotherapy or Chemotherapy Alone for Patients With Lung Cancer (POSEIDON).

This is a randomized, open-label, multi-center, global, Phase III study to determine the efficacy and safety of durvalumab + tremelimumab combination therapy + Standard of care (SoC) chemotherapy or durvalumab monotherapy + SoC chemotherapy versus SoC chemotherapy alone as first line treatment in patients with metastatic non small-cell lung cancer …

Research Site
 (3.3 away) Contact site
  • 714 views
  • 04 Sep, 2021
  • +149 other locations
Early CPAP in Respiratory Distress Syndrome

The purpose of this study is to establish if a strategy of EBCPAP application in a subgroup of VLBWI, 800 to 1500g birthweight, decreases the need for mechanical ventilation in this group, without affecting mortality.

continuous positive airway pressure
mechanical ventilation
intubation
Servicio de Neonatolog a, Hospital Cayetano Heredia
 (4.0 away) Contact site
  • 38 views
  • 07 Nov, 2020
  • +11 other locations
A Study of Lenvatinib (MK-7902) in Pediatric Participants With Relapsed or Refractory Solid Malignancies (MK-7902-013/E7080)

The main purpose of this study is to evaluate the antitumor activity and safety of Lenvatinib (MK-7902/E7080) in children, adolescents, and young adults with relapsed or refractory solid malignancies after administration. Participants will be enrolled into initial tumor-specific cohorts which will be expanded based on observed response.

Clinica Anglo Americana ( Site 0203)
 (3.8 away) Contact site
  • 0 views
  • 27 Sep, 2021
  • +49 other locations
Capivasertib+Fulvestrant vs Placebo+Fulvestrant as Treatment for Locally Advanced (Inoperable) or Metastatic HR+/HER2- Breast Cancer

Phase III, double-blind, randomised study assessing the efficacy of capivasertib + fulvestrant vs placebo + fulvestrant for the treatment of patients with locally advanced (inoperable) or metastatic HR+/HER2- breast cancer following recurrence or progression on or after AI therapy.

Research Site
 (3.1 away) Contact site
  • 52 views
  • 27 Sep, 2021
  • +224 other locations
Sub Arachnoid Neurocysticercosis Treatment Outcome (SANTO)

Taenia solium neurocysticercosis (NCC) is a parasitic infection causing much neurological disease in most of the world. When parasites locate in the cavities around the brain (subarachnoid NCC, SANCC), it becomes an aggressive, progressive and frequently lethal presentation. Current treatment regimens for SANCC have quite limited efficacy. The investigators propose …

Hospital Nacional Cayetano Heredia
 (4.0 away) Contact site
  • 8 views
  • 25 Jan, 2021
  • +1 other locations
Assess Efficacy and Safety of Durvalumab Alone or Combined With Bevacizumab in High Risk of Recurrence HCC Patients After Curative Treatment

A global study to assess the efficacy and safety of durvalumab in combination with bevacizumab or durvalumab alone in patients with hepatocellular carcinoma who are at high risk of recurrence.

durvalumab
bevacizumab
Research Site
 (4.0 away) Contact site
  • 75 views
  • 26 Sep, 2021
  • +249 other locations
Study of Efficacy and Safety of Ligelizumab in Chronic Spontaneous Urticaria Patients Who Completed a Previous Study With Ligelizumab

The purpose of this extension study is to establish efficacy and safety of ligelizumab. This will be assessed in adult and adolescent chronic spontaneous urticaria (CSU) patients who have completed a preceding ligelizumab study and have relapsed, following treatment in these preceding studies, despite standard of care H1-antihistamine (H1-AH) treatment. …

antihistamines
urticaria
ligelizumab
Novartis Investigative Site
 (7.4 away) Contact site
  • 1 views
  • 29 Aug, 2021
  • +229 other locations
Drug-Drug Interactions Between Rifapentine and Dolutegravir in HIV/LTBI Co-Infected Individuals

This study will evaluate the potential drug-drug interactions between dolutegravir (DTG) and steady state rifapentine (RPT) when RPT is given with isoniazid (INH) daily for 4 weeks (1HP) as part of treatment for latent TB infection (LTBI) in HIV-1 and LTBI co-infected individuals.

urine test
antibody test
dolutegravir
interferon-gamma release assay
rifapentine
Barranco CRS
 (7.6 away) Contact site
  • 0 views
  • 30 Aug, 2021
  • +10 other locations
Study of Mavrilimumab (KPL-301) in Participants Hospitalized With Severe Corona Virus Disease 2019 (COVID-19) Pneumonia and Hyper-inflammation

Interventional, randomized, double-blind, placebo-controlled study encompassing 2 development phases (Phase 2 and Phase 3).

SARS
pneumonia
mechanical ventilation
chest x-ray
fever
Clinica Providencia
 (0.7 away) Contact site
  • 122 views
  • 17 Mar, 2021
  • +32 other locations
Evaluating Newly Approved Drugs in Combination Regimens for Multidrug-Resistant TB With Fluoroquinolone Resistance (endTB-Q)

endTB-Q Clinical Trial is a Phase III, randomized, controlled, open-label, non-inferiority, multi-country trial evaluating the efficacy and safety of two new, all-oral, shortened regimens for multidrug-resistant tuberculosis (MDR-TB) with fluoroquinolone resistance.

delamanid
linezolid pill
clofazimine
bedaquiline
linezolid
Socios En Salud
 (4.0 away) Contact site
  • 94 views
  • 17 Sep, 2021
  • +5 other locations